Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
Peter Sever(Imperial College London), Jan Östergren(Karolinska University Hospital), Hans Wedel(Sahlgrenska University Hospital), Jesper Mehlsen(Frederiksberg Hospital), Markku S. Nieminen(Cornell University), Arni Kristinsson(Reykjavík University), Eoin OʼBrien(University College Dublin), Björn Dahlöf(Sahlgrenska University Hospital), Mark J. Caulfield(Queen Mary University of London), Sverre E. Kjeldsen(Oslo University Hospital), Rory Collins(University of Oxford), Gordon T. McInnes(University of Glasgow), Neil R Poulter(Imperial College London), Gareth Beevers(Birmingham City Hospital)
Cited by 3,792
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k